These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Atovaquone and proguanil hydrochloride for treatment of malaria. Kremsner PG, Looareesuwan S, Chulay JD. J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548 [Abstract] [Full Text] [Related]
4. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria. McKeage K, Scott L. Drugs; 2003 May; 63(6):597-623. PubMed ID: 12656656 [Abstract] [Full Text] [Related]
6. [Value of malarone in therapy of malaria tropica]. Ziegler T, Schau A, Winkler C. Med Klin (Munich); 2002 Aug 15; 97(8):455-8. PubMed ID: 12229244 [Abstract] [Full Text] [Related]
8. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model. Deye GA, Miller RS, Miller L, Salas CJ, Tosh D, Macareo L, Smith BL, Fracisco S, Clemens EG, Murphy J, Sousa JC, Dumler JS, Magill AJ. Clin Infect Dis; 2012 Jan 15; 54(2):232-9. PubMed ID: 22052893 [Abstract] [Full Text] [Related]
9. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand. Khositnithikul R, Tan-Ariya P, Mungthin M. Malar J; 2008 Jan 28; 7():23. PubMed ID: 18226262 [Abstract] [Full Text] [Related]
13. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team. Høgh B, Clarke PD, Camus D, Nothdurft HD, Overbosch D, Günther M, Joubert I, Kain KC, Shaw D, Roskell NS, Chulay JD, Malarone International Study Team. Lancet; 2000 Dec 02; 356(9245):1888-94. PubMed ID: 11130385 [Abstract] [Full Text] [Related]
14. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women. Na-Bangchang K, Manyando C, Ruengweerayut R, Kioy D, Mulenga M, Miller GB, Konsil J. Eur J Clin Pharmacol; 2005 Sep 02; 61(8):573-82. PubMed ID: 16041597 [Abstract] [Full Text] [Related]
15. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria. Nakato H, Vivancos R, Hunter PR. J Antimicrob Chemother; 2007 Nov 02; 60(5):929-36. PubMed ID: 17848375 [Abstract] [Full Text] [Related]
16. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America. Legrand E, Demar M, Volney B, Ekala MT, Quinternet M, Bouchier C, Fandeur T, Rogier C, Carme B, Puijalon OM, Esterre P. Antimicrob Agents Chemother; 2007 Jun 02; 51(6):2280-1. PubMed ID: 17438062 [No Abstract] [Full Text] [Related]
17. Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru. Llanos-Cuentas A, Campos P, Clendenes M, Canfield CJ, Hutchinson DB. Braz J Infect Dis; 2001 Apr 02; 5(2):67-72. PubMed ID: 11493411 [Abstract] [Full Text] [Related]
18. [Fluindione and falciparum malaria treated by atovaquone-proguanil]. Kamaliddin C, Joste V, Argy N, Houzé S. Therapie; 2018 Oct 02; 73(5):445-447. PubMed ID: 29680373 [No Abstract] [Full Text] [Related]
19. Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan. Hitani A, Nakamura T, Ohtomo H, Nawa Y, Kimura M. J Infect Chemother; 2006 Oct 02; 12(5):277-82. PubMed ID: 17109092 [Abstract] [Full Text] [Related]
20. Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group. Kimura M, Koga M, Kikuchi T, Miura T, Maruyama H. Parasitol Int; 2012 Sep 02; 61(3):466-9. PubMed ID: 22484597 [Abstract] [Full Text] [Related] Page: [Next] [New Search]